Publication:
Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: Report from a participatory workshop

dc.contributor.authorHolly L. Peayen_US
dc.contributor.authorNuchanart Q. Ormsbyen_US
dc.contributor.authorGail E. Hendersonen_US
dc.contributor.authorThidarat Jupimaien_US
dc.contributor.authorStuart Rennieen_US
dc.contributor.authorKrittaecho Siripassornen_US
dc.contributor.authorKunakorn Kanchaweeen_US
dc.contributor.authorSinéad Isaacsonen_US
dc.contributor.authorR. Jean Cadiganen_US
dc.contributor.authorKriste Kuczynskien_US
dc.contributor.authorUdom Likhitwonnawuten_US
dc.contributor.otherRTI Internationalen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherThe University of North Carolina at Chapel Hillen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand National CAB on HIV researchen_US
dc.contributor.otherBamrasnaradura Infectious Diseases Instituteen_US
dc.date.accessioned2020-12-28T06:11:32Z
dc.date.available2020-12-28T06:11:32Z
dc.date.issued2020-11-01en_US
dc.description.abstract© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Background: The social/behavioral HIV Decision-Making Study (DMS) assesses informed consent and trial experiences of individuals in HIV remission trials in Thailand. We convened a 1-d multi-stakeholder participatory workshop in Bangkok. We provide a meeting summary and reactions from DMS investigators. Methods: Workshop members viewed de-identified interview excerpts from DMS participants. They deliberated on the findings and made recommendations regarding informed choice for remission trials. Notes and recordings were used to create a summary report, which was reviewed by members and refined. Results: Workshop members’ recommendations included HIV education and psychosocial support to establish the basis for informed choice, key trial information to be provided in everyday language, supportive decision-making processes and psychosocial care during and after the trial. Concerns included participant willingness to restart antiretrovirals after trial-mandated treatment interruption, unintended influence of the research team on decision-making and seemingly altruistic motivations for trial participation that may signal attempts to atone for stigmatized behavior. Conclusions: The workshop highlighted community perspectives and resulted in recommendations for supporting informed choice and psychosocial and physical health. These are the first such recommendations arising from a deliberative process. Although some elements are rooted in the Thai context, most are applicable across remission trials.en_US
dc.identifier.citationInternational Health. Vol.12, No.6 (2020), 567-574en_US
dc.identifier.doi10.1093/inthealth/ihaa067en_US
dc.identifier.issn18763405en_US
dc.identifier.issn18763413en_US
dc.identifier.other2-s2.0-85095979231en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/60576
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85095979231&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleRecommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: Report from a participatory workshopen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85095979231&origin=inwarden_US

Files

Collections